Reuters logo
BRIEF-Cytokinetics announces new data on ALS/MND
December 9, 2016 / 1:12 PM / in a year

BRIEF-Cytokinetics announces new data on ALS/MND

Dec 9 (Reuters) - Cytokinetics Inc

* Cytokinetics announces new data presented at the international symposium on ALS/MND

* Patient baseline characteristics from vitality-ALS comparable to benefit-ALS

* Approximately 24 percent of patients withdrew from vitality-ALS during two week open-label phase, primarily due to aes

* “Look forward to sharing full results from vitality-ALS in late 2017” Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below